FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a method for assessing clinical effectiveness in patients with chronic brucellosis. Disclosed method consists in that in patients with chronic brucellosis in phase of aggravated therapy and on its end is determination of serum level of FNO α, IFN γ, IL 10, is calculated ratio IFN γ /IL 10. When stored after therapeutic course high expression in blood FNO α and IL 10 is 1.5 times higher than in a group of healthy individuals and more; reduced 2 times and more serum level of IFN γ; and reduced in 2.5 times and more as compared with healthy individuals ratio IFN γ /IL 10, treatment is considered to be inadequate.
EFFECT: method enables to determine need for additional therapeutic measures, thereby improving quality of treating patients with chronic brucellosis.
1 cl, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENT WITH CHRONIC BRUCELLOSIS | 2009 |
|
RU2423143C2 |
| METHOD FOR PREDICTING EFFICIENCY OF INTERFERONOTHERAPY AT CHRONIC HEPATITIS B | 2005 |
|
RU2287826C1 |
| DIAGNOSTICS TECHNIQUE FOR ACTIVE OPIUM ADDICTION IN PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C | 2010 |
|
RU2417759C1 |
| METHOD OF TREATING LICHEN ACUMINATUS IN ORAL MUCOSA | 2011 |
|
RU2510269C2 |
| METHOD FOR TREATING CHLAMYDIA-CAUSED PROSTATITIS CASES | 2006 |
|
RU2307656C1 |
| METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
| METHOD FOR PREDICTING THE FLOW OF INFECTIOUS MONONUCLEOSIS CAUSED WITH EPSTEIN-BARR VIRUS IN CHILDREN | 2005 |
|
RU2285262C1 |
| METHOD OF TREATING INFLUENZA AND INFLUENZA-LIKE ILLNESSES COMPLICATED WITH PNEUMONIA | 2012 |
|
RU2518277C2 |
| METHOD OF TREATING CHRONIC PROSTATITIS | 2008 |
|
RU2408378C2 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2012 |
|
RU2486526C1 |
